Top Markets
Coin of the day
Baudax Bio, Inc. Baudax Bio, Inc.

Baudax Bio, Inc.

BXRXQ
Rangering i aksjer #42133
Baudax Bio, Inc., a biotechnology company, develops and commercializes products... Baudax Bio, Inc., a biotechnology company, develops and commercializes products for hospital and other acute care related settings. The company develops T cell receptor, that focus on immune modulating therapies for orphan diseases or complications associated with such diseases, as well as the treatment of autoimmune disorders. It also develops BX1000, an intermediate-acting neuromuscular blocking agent (NMB) that is in phase II clinical trial; BX2000, an ultra- short acting NMB, which is in phase I clinical trial, as well as a proprietary blockade reversal agent; and BX3000, a NMB reversal agent that is in preclinical studies. Baudax Bio, Inc. was incorporated in 2015 and is based in Malvern, Pennsylvania. On February 22, 2024, Baudax Bio, Inc. filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the Eastern District of Pennsylvania.
Aksjekurs
$0.0001
Sist synkronisert: 2026-08-11
Markedsverdi
$4.36K
Endring (1 dag)
0.00%
Endring (1 år)
9,900.00%
Land
US
Handel Baudax Bio, Inc. (BXRXQ)

Kategori

Historikk for aksjesplitt for Baudax Bio, Inc. (BXRXQ)
Aksjen Baudax Bio, Inc. (symbol: BXRXQ) har gjennomgått totalt 0 aksjesplitt.
Den nyeste splittelsen skjedde Aug 12, 2026.
Én BXRXQ-aksje kjøpt før Aug 12, 2026 tilsvarer i dag 0 BXRXQ-aksjer.
Liste over aksjesplitt
År Splitt Multiplikator Kumulativ multiplikator
Ikke nok data for de angitte datoene.
Aksjesplitt for lignende selskaper eller konkurrenter
Selskap Antall aksjesplitt Kumulativ multiplikator Land
1 x2
US
0 -
NL
0 -
CH
0 -
BE
0 -
KR